Clinical Trial Update: Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the safety, efficacy, and dose titration of Sodium Oligo-mannurarate capsules in mild-to-moderate Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Sodium Oligo-mannurarate Capsule (sodium oligo-mannurarate)

Snippet

Sponsor: Shanghai Greenvalley Pharmaceutical Co., Ltd. | Conditions: Alzheimer Disease, Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2015-01-27